期刊文献+

血液透析合并感染性心内膜炎的临床研究进展 被引量:3

下载PDF
导出
摘要 血液透析(hemodailysis,HD)是急慢性肾衰竭患者肾脏替代治疗(renal replacement theraoy,RRT)的方法之一。除此之外,终末期肾脏病(end stage renal disease,ESRD)患者的治疗手段还包括腹膜透析、肾脏移植及中药治疗等,而ESRD患者发生心血管危险事件的风险极高,特别是接受ID的患者,其中较为凶险的当属感染性心内膜炎(Infective endocarditis,IE)。
出处 《中国中西医结合肾病杂志》 2019年第6期556-558,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献7

二级参考文献47

  • 1孟蔚(韦华).维持性血液透析患者感染性心内膜炎的研究进展[J].甘肃科技纵横,2007,36(2):221-222. 被引量:4
  • 2McLaughlin VV. Looking to the future: a new decade of pulmonary arterial hypertension therapy. Eur Respir J 2011; 20: 262-9.
  • 3Mathew R. Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity. Am J PhysioI-Heart C 2014; 306: H15-25.
  • 4Rosanio S, Pelliccia F, Gaudio C, Greco C, Keylani AM, D'Agostino DC. Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Biomed Res Int 2014; 2014: 743868.
  • 5Zamanian RT, Kudelko KT, SungYK, de Jesus PerezV, Liu J, Spiekerkoetter E. Current clinical management of pulmonary arterial hypertension. Circ Res 2014; 115: 131-47.
  • 6Han C, Hong KH, Kim YH, Kim M J, Song C, Kim M J, et al. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension. Hypertension 2013; 61: 1044-52.
  • 7Upton PD, Davies R J, Tajsic T, Morrell NW. Transforming growth factor- beta(l) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3. Am J Resp Cell Mol 2013; 49: 1135-45.
  • 8Yang J, Davies R J, Southwood M, Long L, Yang X, Sobolewski A, et al. Mutations in bone morphogenetic protein type Ⅱ receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res 2008; 102: 1212-21.
  • 9Nishikawa-Takahashi M, Ueno S, Kario K. Long-term advanced therapy with bosentan improves symptoms and prevents deterioration of inoperable chronic thromboembelic pulmonary hypertension. Life Sci 2014; 118: 410-3.
  • 10Fontoura D, Oliveira-Pinto J, Tavares-Silva M, Leite S, Vasques-Novoa F, Mendes-Ferreira P, et al. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension. Rev Port Cardio12014; 33: 213-22.

共引文献29

同被引文献27

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部